Mark P. Hertzberg

Tufts University — United States

Physics and Astronomy · Physical Sciences

30h-index4.8kcitations147works9.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cosmology and Gravitation Theories(102), Black Holes and Theoretical Physics(43), Dark Matter and Cosmic Phenomena(42), Galaxies: Formation, Evolution, Phenomena(19), Particle physics theoretical and experimental studies(19)

Publications147 total

Unitarity, causality, and solar system bounds may significantly limit the use of gravitational waves to test general relativity
Journal of High Energy Physics·2025Open Access
Effects of New Forces on Scalar Dark Matter Solitons
arXiv (Cornell University)·2025Open Access
Clinical outcomes with venetoclax-based therapy in patients with relapsed/refractory B-cell lymphomas
Leukemia & lymphoma/Leukemia and lymphoma·2025
PROs vs clinician-reported adverse events in a large clinical trial: findings from the phase 3 POLARIX study
Blood·2025· 1 citedOpen Access
Comparing Minimal and Non-Minimal Quintessence Models to 2025 DESI Data
arXiv (Cornell University)·2025Open Access
Neutron stars in causal scalar-tensor theories
Physical review. D/Physical review. D.·2025· 1 citedOpen Access
Solar System constraints on light propagation from higher derivative corrections to general relativity and implications for fundamental physics
Physical review. D/Physical review. D.·2025· 2 citedOpen Access
Inconsistency with de Sitter spacetime in a new approach to gravitational particle production
Physics of the Dark Universe·2025
<scp>CD19</scp> Directed <scp>CAR</scp> T Therapy for Transformed Follicular Lymphoma: A <scp>CIBMTR</scp> Analysis
American Journal of Hematology·2025
Examining quintessence models with DESI data
Journal of Cosmology and Astroparticle Physics·2025· 11 citedOpen Access
Fertility in patients with advanced-stage classic Hodgkin lymphoma treated with BrECADD versus eBEACOPP: a secondary analysis of the multicentre, randomised, parallel, open-label, phase 3 HD21 trial
Open Access CRIS of the University of Bern·2025Open Access
Probability of the initial conditions for inflation and slow contraction
Physical review. D/Physical review. D.·2025Open Access
Positron Emission Tomography–Guided Brentuximab Vedotin, Etoposide, Cyclophosphamide, Doxorubicin, Dacarbazine, and Dexamethasone in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma: A Prospective, Multicenter, Single-Arm, Phase II Cohort of the German Hodgkin Study Group HD21 Trial
Journal of Clinical Oncology·2025· 5 cited
Glofitamab Combined With Pola-R-CHP or R-CHOP as First Therapy in Younger Patients With High-Risk Large B-Cell Lymphoma: Results From the COALITION Study
Journal of Clinical Oncology·2025· 5 cited
356 | METABOLIC TUMOR VOLUME IN OLDER PATIENTS WITH ADVANCED‐STAGE CLASSIC HODGKIN LYMPHOMA: RESULTS FROM THE GHSG HD21 TRIAL
Hematological Oncology·2025Open Access
Precision Unitarity Calculations in Inflationary Models
arXiv (Cornell University)·2025Open Access
Black holes rule out heavy tachyons
Physical review. D/Physical review. D.·2025
Black Holes Rule Out Heavy Tachyons
arXiv (Cornell University)·2025Open Access
Inconsistency with De Sitter Spacetime in a New Approach to Gravitational Particle Production
SSRN Electronic Journal·2025Open Access
Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial
The Lancet·2024· 116 cited
page 1 of 8Next →

Frequent Co-authors

Johanna Karouby(6), Enrico D. Schiappacasse(6), Frank Wilczek(4), Daniel Baumann(3), Mark Jackson(3), Asantha Cooray(3), Scott Dodelson(3), Richard Easther(3), Raphael Flauger(3), Shamit Kachru(3), Matías Zaldarriaga(3), Mehran Kardar(3), Tsutomu T. Yanagida(3), N. F. Cramer(3), S. V. Vladimirov(3), Fabrizio Rompineve(3), Mustafa A. Amin(2), Peter Adshead(2), Alexandre Amblard(2), Amjad Ashoorioon(2)